Cargando…
PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429689/ http://dx.doi.org/10.1097/01.HS9.0000851120.44523.52 |
| _version_ | 1784779537041588224 |
|---|---|
| author | Basturk, A. Bagci, M. Dal, M. S. Hacibekiroglu, T. Kabukcu Hacioglu, S. Aydogdu, I. Kizil Cakar, M. Sunu, C. Akgun Cagliyan, G. Kaya, A. Dogu, M. H. Celik, S. Uskudar Teke, H. Erkurt, M. A. Ekinci, O. Turgut, B. Tekinalp, A. Korkmaz, S. Ulas, T. Altuntas, F. |
| author_facet | Basturk, A. Bagci, M. Dal, M. S. Hacibekiroglu, T. Kabukcu Hacioglu, S. Aydogdu, I. Kizil Cakar, M. Sunu, C. Akgun Cagliyan, G. Kaya, A. Dogu, M. H. Celik, S. Uskudar Teke, H. Erkurt, M. A. Ekinci, O. Turgut, B. Tekinalp, A. Korkmaz, S. Ulas, T. Altuntas, F. |
| author_sort | Basturk, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429689 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94296892022-08-31 PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA Basturk, A. Bagci, M. Dal, M. S. Hacibekiroglu, T. Kabukcu Hacioglu, S. Aydogdu, I. Kizil Cakar, M. Sunu, C. Akgun Cagliyan, G. Kaya, A. Dogu, M. H. Celik, S. Uskudar Teke, H. Erkurt, M. A. Ekinci, O. Turgut, B. Tekinalp, A. Korkmaz, S. Ulas, T. Altuntas, F. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429689/ http://dx.doi.org/10.1097/01.HS9.0000851120.44523.52 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Basturk, A. Bagci, M. Dal, M. S. Hacibekiroglu, T. Kabukcu Hacioglu, S. Aydogdu, I. Kizil Cakar, M. Sunu, C. Akgun Cagliyan, G. Kaya, A. Dogu, M. H. Celik, S. Uskudar Teke, H. Erkurt, M. A. Ekinci, O. Turgut, B. Tekinalp, A. Korkmaz, S. Ulas, T. Altuntas, F. PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA |
| title | PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA |
| title_full | PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA |
| title_fullStr | PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA |
| title_full_unstemmed | PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA |
| title_short | PB2072: EFFICACY AND SIDE EFFECTS OF IBRUTINIB IN RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA |
| title_sort | pb2072: efficacy and side effects of ibrutinib in relapsed and refractory mantle cell lymphoma |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429689/ http://dx.doi.org/10.1097/01.HS9.0000851120.44523.52 |
| work_keys_str_mv | AT basturka pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT bagcim pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT dalms pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT hacibekiroglut pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT kabukcuhacioglus pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT aydogdui pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT kizilcakarm pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT sunuc pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT akguncagliyang pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT kayaa pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT dogumh pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT celiks pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT uskudartekeh pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT erkurtma pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT ekincio pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT turgutb pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT tekinalpa pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT korkmazs pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT ulast pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma AT altuntasf pb2072efficacyandsideeffectsofibrutinibinrelapsedandrefractorymantlecelllymphoma |